Vera Therapeutics, Inc. SEC filings VERA
Vera Therapeutics, Inc. has 476 filings in SEC EDGAR's recent list, going back to Feb 25, 2021. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 15, 2026 | Sep 15, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Other events
|
Jul 7, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Other events
|
Jun 2, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2026 | — |
| DEF 14A | Proxy statement | Apr 9, 2026 | May 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2026 | Mar 5, 2026 |
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Other events
|
Dec 10, 2025 | Dec 9, 2025 |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| 424B5 | Prospectus supplement | Dec 8, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 26, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Aug 5, 2025 | Aug 5, 2025 |
| 424B5 | Prospectus supplement | Aug 5, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 3, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 3, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 3, 2025 | — |
| DEF 14A | Proxy statement | Apr 3, 2025 | May 14, 2025 |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Oct 31, 2024 | Oct 29, 2024 |
| 424B5 | Prospectus supplement | Oct 30, 2024 | — |
| 424B5 | Prospectus supplement | Oct 29, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 28, 2024 | Oct 26, 2024 |
| S-3ASR | Automatic shelf registration | Oct 28, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 2, 2024 | Oct 2, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 17, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| DEFA14A | Additional proxy material | May 3, 2024 | — |
| ARS | Annual report to shareholders | Apr 4, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 3, 2024 | — |
| DEF 14A | Proxy statement | Apr 3, 2024 | May 15, 2024 |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Other events
|
Jan 30, 2024 | Jan 29, 2024 |
| 424B5 | Prospectus supplement | Jan 30, 2024 | — |
| S-3MEF | Filing | Jan 29, 2024 | — |
| 424B5 | Prospectus supplement | Jan 29, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jan 29, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 25, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
New debt
|
Dec 26, 2023 | Dec 22, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 20, 2023 | Jun 17, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 17, 2023 | May 10, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | Mar 30, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 30, 2023 | — |
| DEF 14A | Proxy statement | Mar 30, 2023 | May 10, 2023 |
| S-8 | Employee stock plan registration | Mar 28, 2023 | — |
| 10-K | Annual report | Mar 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Other events
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Other events
|
Feb 2, 2023 | Feb 1, 2023 |
| 424B5 | Prospectus supplement | Feb 2, 2023 | — |
| 424B5 | Prospectus supplement | Feb 1, 2023 | — |
| 8-K |
Current report
Results of operations
|
Feb 1, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 30, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 3, 2023 | Jan 3, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 9, 2022 | Sep 9, 2022 |
| 424B5 | Prospectus supplement | Sep 9, 2022 | — |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 424B5 | Prospectus supplement | Jun 14, 2022 | — |
| 424B5 | Prospectus supplement | Jun 14, 2022 | — |
| EFFECT | Filing | Jun 13, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2022 | — |
| CORRESP | Letter to the SEC | Jun 9, 2022 | — |
| S-3 | Shelf registration | Jun 3, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2022 | May 24, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| DEFA14A | Additional proxy material | Apr 14, 2022 | — |
| DEF 14A | Proxy statement | Apr 14, 2022 | May 24, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2022 | Apr 7, 2022 |
| S-8 | Employee stock plan registration | Mar 28, 2022 | — |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2022 | Mar 24, 2022 |
| 424B4 | Prospectus | Feb 11, 2022 | — |
| S-1MEF | Filing | Feb 10, 2022 | — |
| EFFECT | Filing | Feb 9, 2022 | — |
| CORRESP | Letter to the SEC | Feb 7, 2022 | — |
| CORRESP | Letter to the SEC | Feb 7, 2022 | — |
| S-1 | Registration statement | Feb 7, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2022 | — |
| DRS | Filing | Jan 4, 2022 | — |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Dec 17, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2021 | Dec 10, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2021 | Jul 14, 2021 |
| 10-Q | Quarterly report | Jun 24, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Jun 24, 2021 | Jun 24, 2021 |
| S-8 | Employee stock plan registration | May 18, 2021 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 18, 2021 | May 18, 2021 |
| 424B4 | Prospectus | May 17, 2021 | — |
| EFFECT | Filing | May 13, 2021 | — |
| SEC STAFF LETTER | Filing | May 13, 2021 | — |
| CERT | Filing | May 13, 2021 | — |
| CORRESP | Letter to the SEC | May 12, 2021 | — |
| CORRESP | Letter to the SEC | May 12, 2021 | — |
| CORRESP | Letter to the SEC | May 12, 2021 | — |
| S-1/A | Amended registration statement | May 12, 2021 | — |
| 8-A12B | Filing | May 11, 2021 | — |
| UPLOAD | Letter from the SEC | May 10, 2021 | — |
| CORRESP | Letter to the SEC | May 10, 2021 | — |
| S-1/A | Amended registration statement | May 10, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2021 | — |
| CORRESP | Letter to the SEC | Apr 23, 2021 | — |
| S-1 | Registration statement | Apr 23, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 15, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2021 | — |
| DRS | Filing | Mar 19, 2021 | — |
| D | Filing | Feb 25, 2021 | — |
Showing 154 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VERA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1831828
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.